CASI Pharmaceuticals
CASI
#10374
Rank
NZ$7.28 M
Marketcap
NZ$0.35
Share price
0.00%
Change (1 day)
-90.41%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.73. In 2024 the company made an earnings per share (EPS) of NZ-$4.37 a decrease over its 2023 EPS that were of NZ-$3.45.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.656.35%
2024NZ-$4.3726.73%
2023NZ-$3.45-32.89%
2022NZ-$5.1411.9%
2021NZ-$4.60-38.44%
2020NZ-$7.47-8.96%
2019NZ-$8.2050%
2018NZ-$5.4777.78%
2017NZ-$3.085.88%
2016NZ-$2.90-22.73%
2015NZ-$3.76-76.09%
2014NZ-$15.72318.18%
2013NZ-$3.76-71.79%
2012NZ-$13.3365.96%
2011NZ-$8.03-50%
2010NZ-$16.06-18.97%
2009NZ-$19.82-63.64%
2008NZ-$54.503.57%
2007NZ-$52.62-60.56%
2006NZ-$133.4397.22%
2005NZ-$67.65-2.7%
2004NZ-$69.53-45.59%
2003NZ-$127.79-61.8%
2002NZ-$334.51-25.52%
2001NZ-$449.14-21.38%
2000NZ-$571.2913.86%
1999NZ-$501.76149.53%
1998NZ-$201.0898.15%
1997NZ-$101.4810.2%
1996NZ-$92.08